Terguride

Terguride
Clinical data
Trade names	Teluron
Other names	Dironyl; Mysalfon; trans-Dihydrolisuride; Transdihydrolisuride; TDHL; SH-406; VUFB-6638; ZK-31224; N,N-Diethyl-N'-[(8α)-6-methylergolin-8-yl]urea
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	G02CB06 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 3-[(6aR,9S,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea;
CAS Number	37686-84-3;
PubChem CID	443951;
IUPHAR/BPS	56;
DrugBank	DB13399 ;
ChemSpider	392004;
UNII	21OJT43Q88;
KEGG	D01348 ;
CompTox Dashboard (EPA)	DTXSID3045809 ;
ECHA InfoCard	100.048.732
Chemical and physical data
Formula	C20H28N4O
Molar mass	340.471 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)C(=O)N[C@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C;
	InChI InChI=1S/C20H28N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,11,14,16,18,21H,4-5,9-10,12H2,1-3H3,(H,22,25)/t14-,16+,18+/m0/s1; Key:JOAHPSVPXZTVEP-YXJHDRRASA-N;
	(verify)

Terguride (INNTooltip International Nonproprietary Name, JANTooltip Japanese Accepted Name), sold under the brand name Teluron, is a serotonin receptor antagonist and dopamine receptor agonist of the ergoline family. It is approved for and used as a prolactin inhibitor in the treatment of hyperprolactinemia (high prolactin levels) in Japan. Terguride is taken by mouth.